Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 473.82 -1.13 (-0.24%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy? Today 4:12 EDT It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes. Via The Motley Fool Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead June 21, 2024 Lilly is a good pick...but this one is better. Via The Motley Fool Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX. June 20, 2024 NASDAQ:VRTX is not too expensive for the growth it is showing. Via Chartmill Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years June 18, 2024 Via Benzinga 3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation June 18, 2024 Evergreen business models make it easier to hold for the long run. Via The Motley Fool 13 Analysts Have This To Say About Vertex Pharmaceuticals June 17, 2024 Via Benzinga Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)? June 12, 2024 Why NASDAQ:VRTX Stands Out as a Quality Stock. Via Chartmill $1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today June 05, 2024 Via Benzinga This Is What Whales Are Betting On Vertex Pharmaceuticals June 03, 2024 Via Benzinga Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' June 17, 2024 On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named ConocoPhillips, and Rob Sechan suggested AbbVie, with all four stocks having... Via Benzinga 3 Growth Stocks You Can Buy Right Now Without Any Hesitation June 15, 2024 Want peace of mind about your investments? Consider these great stocks. Via The Motley Fool 2 Healthcare Stocks to Buy Hand Over Fist in June June 12, 2024 They both have pretty impressive pasts, and their prospects look just as bright. Via The Motley Fool Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday June 11, 2024 Via Benzinga Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO June 10, 2024 Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services. Via Talk Markets Analyst Expectations For Vertex Pharmaceuticals's Future May 31, 2024 Via Benzinga While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable. May 29, 2024 NASDAQ:VRTX is showing decent growth, but is still valued reasonably. Via Chartmill 2 Biotech Stocks to Buy in May May 25, 2024 You could buy these in any month, really. Via The Motley Fool Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought June 09, 2024 These companies could generate explosive growth over time. Via The Motley Fool Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst June 07, 2024 Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety . Via Benzinga Large Cap BIopharmaceuticals Overview June 03, 2024 As a defensive play healthcare is weighted at about 12% of the S&P 500. Via Talk Markets Topics Stocks Exposures US Equities 3 No-Brainer Stocks to Buy in June June 02, 2024 Now is the time to invest in these great stocks. Via The Motley Fool 5 Top Stocks to Buy in June June 02, 2024 This medley of growth, value, and income stocks is poised to thrive long-term, even if the stock market sells off this summer. Via The Motley Fool S&P 500 Giants Lead Five Healthy Stocks Near Buy Points June 01, 2024 Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry. Via Investor's Business Daily Topics Stocks Exposures US Equities A Very Bullish Reversal Produces A Huge Batch Of Actionable Stocks May 31, 2024 It is very hard to get excited about what I'm seeing in the stock market because things have not been the way I've wanted them to be. In this video, I want to show you something as we look at a monthly... Via Talk Markets Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists May 31, 2024 Vertex stock was one of a select group of eight that made it onto IBD top-stocks lists Friday. The big pharma is near its all-time high. Via Investor's Business Daily Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? May 30, 2024 Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat. Via The Motley Fool Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic May 28, 2024 Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function. Via Benzinga Got $500? 3 Pharma Stocks to Buy and Hold Forever May 26, 2024 These players might even beat the market when the conditions are right. Via The Motley Fool Is It Too Late to Buy Vertex Pharmaceuticals Stock? May 26, 2024 Shares of the growing biotech company have doubled in three years. Via The Motley Fool 3 High-Flying Stocks That Could Soar Even More May 25, 2024 The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals. Via The Motley Fool < Previous 1 2 3 4 5 6 7 8 9 ... 43 44 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.